Cross-sectional Characterization of Idiopathic Bronchiectasis | MicrobiomeTrials← Back to trialsNCT01264055
Cross-sectional Characterization of Idiopathic Bronchiectasis
CompletedOBSERVATIONAL
Trial Details
Enrollment target: 275 participants Locations- Stanford Medical Center, Stanford, California, United States
- National Jewish Health, Denver, Colorado, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Washington University, St. Louis, St Louis, Missouri, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- St. Michael's Hospital, Toronto, Canada
Other microbiome trials you might be interested in
Bronchiectasis Adult
Study design: observational, retrospective Population: 270 patients diagnosed with bronchiectasis (BX) treated at the Re…
A Coruña, SpainEst. completion Oct 1, 2026
TraumaVascular System Injury
This study evaluates the use of the Acellular Tissue Engineered Vessel (ATEV) in adults with vascular trauma below the n…
La Jolla, United StatesCompleted Sep 19, 2023
HIV-1-infectionMetabolic Syndrome
This study is being done to understand how a physical activity walking intervention affects metabolic parameters (i.e., …
Washington D.C., United StatesCompleted Jun 11, 2025